These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27518527)

  • 1. Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report.
    Ravindra VM; Raheja A; Corn H; Driscoll M; Welt C; Simmons DL; Couldwell WT
    J Neurosurg; 2017 May; 126(5):1725-1730. PubMed ID: 27518527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
    Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acromegaly and pheochromocytoma: report of a rare coexistence.
    Sleilati GG; Kovacs KT; Honasoge M
    Endocr Pract; 2002; 8(1):54-60. PubMed ID: 11939762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in pituitary hyperplasia.
    Vidal S; Horvath E; Kovacs K; Lloyd RV; Smyth HS
    Mod Pathol; 2001 Jan; 14(1):20-8. PubMed ID: 11211306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent, transformed non-Hodgkin's lymphoma presenting as chiasmal syndrome with hyperprolactinemia and hypopituitarism.
    Sumrall A; Herrin V
    J Miss State Med Assoc; 2010 Feb; 51(2):35-6. PubMed ID: 20827870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
    Ezzat S; Asa SL; Stefaneanu L; Whittom R; Smyth HS; Horvath E; Kovacs K; Frohman LA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):555-60. PubMed ID: 8126126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma.
    Vieira Neto L; Taboada GF; Corrêa LL; Polo J; Nascimento AF; Chimelli L; Rumilla K; Gadelha MR
    Endocr Pathol; 2007; 18(1):46-52. PubMed ID: 17652801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: case report.
    Altstadt TJ; Azzarelli B; Bevering C; Edmondson J; Nelson PB
    Neurosurgery; 2002 Jun; 50(6):1356-9; discussion 1360. PubMed ID: 12015856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
    Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
    Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
    Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
    Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Crooke cell adenoma in a patient with diffuse large B-cell lymphoma.
    Schwann K; Bogiatzi C; Algird A; Lu JQ
    J Clin Neurosci; 2020 Mar; 73():318-321. PubMed ID: 31937501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series.
    Kawaguchi T; Ogawa Y; Tominaga T
    J Med Case Rep; 2019 Mar; 13(1):85. PubMed ID: 30862315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
    Roberts E; Oncale M; Safah H; Schmieg J
    J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.